Overview
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
Status:
Completed
Completed
Trial end date:
2007-08-01
2007-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alcon ResearchTreatments:
Ophthalmic Solutions
Travoprost
Criteria
Inclusion Criteria:- Adults with a clinical diagnosis of ocular hypertension, or primary open-angle,
pigment dispersion or exfoliation glaucoma in at least one eye (study eye)
Exclusion Criteria:
- Age